- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-22-0035087

NBM Pharmaceuticals Private Limited
About NBM Pharmaceuticals Private Limited
Data last updated:
NBM Pharmaceuticals Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2020PTC070609. Its GSTIN is 08AAHCN1247Q1ZY (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ram Swaroop Bishnoi and Prashant Bishnoi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N 1643 Pn 38 Virender Nagar, Jodhpur, Rajasthan, India – 342007.
As per the financials filed for FY 2025, the company reported a revenue of ₹94.22 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹22,714 (net margin 0.2%) and EBITDA of ₹51,359 (EBITDA margin 0.5%).
NBM Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-22-0035087).
Company details
Recognitions & Rankings of NBM Pharmaceuticals
Contact details
NBM Pharmaceuticals Private Limited's registered office is in Jodhpur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressN 1643 Pn 38 Virender Nagar, Jodhpur, Rajasthan, India – 342007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of NBM Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of NBM Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of NBM Pharmaceuticals Private Limited, buy the company report.
Financials of NBM Pharmaceuticals Private Limited
FY 2025 filings availableNBM Pharmaceuticals Private Limited reported revenue of ₹94.22 Lakh (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 37% in the latest year. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51,359 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22,714 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of NBM Pharmaceuticals Private Limited, buy the company report.
Board of directors of NBM Pharmaceuticals Private Limited
NBM Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Swaroop Bishnoi | Director | 28 Aug 2020 | 6 Years 1 Months | Current |
| Prashant Bishnoi | Director | 28 Aug 2020 | 6 Years 1 Months | Current |
Peer comparison
NBM Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trivet Pharmaceuticals Private Limited | ₹94.96 Lakh (FY 2024) | -7.0% | Karnal, Haryana, India | |||
| Orbit Chem Pharmaceuticals Private Limited | ₹94.95 Lakh (FY 2024) | -51.0% | Cherapalli, Telangana, India | |||
| NBM Pharmaceuticals Private Limitedthis company | ₹94.22 Lakh (FY 2025) | ₹22,714 | 0.2% | 37.0% | Jodhpur, Rajasthan, India | |
| Gifs Plus Pharmaceuticals Private Limited | ₹93.7 Lakh (FY 2025) | -3.0% | Washim, Maharashtra, India |
To see the full peer comparison of NBM Pharmaceuticals Private Limited, buy the company report.
Auditor
NBM Pharmaceuticals Private Limited is audited by RATHI PANKAJ & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RATHI PANKAJ & ASSOCIATES | FY 2023 | 417084 |
Shareholding
The shareholding of NBM Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of NBM Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving NBM Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for NBM Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
NBM Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
NBM Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAHCN1247Q1ZY | Rajasthan | Active | 14 Mar 2023 |
To see the full GST registrations and return filing status of NBM Pharmaceuticals Private Limited, buy the company report.
Recent activity
NBM Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Prashant Bishnoi was appointed as Director on 28 Aug 2020.
Frequently asked questions
NBM Pharmaceuticals is an active private limited company based in Jodhpur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 August 2020 (6+ years old) and is registered under CIN U24100RJ2020PTC070609.
NBM Pharmaceuticals has 2 current directors:
- Ram Swaroop Bishnoi - Director
- Prashant Bishnoi - Director
The latest financial statements of NBM Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of NBM Pharmaceuticals is 08AAHCN1247Q1ZY, registered in Rajasthan.
The CIN (Corporate Identification Number) of NBM Pharmaceuticals is U24100RJ2020PTC070609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NBM Pharmaceuticals was incorporated on 28 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of NBM Pharmaceuticals by revenue are Trivet Pharmaceuticals Private Limited, Orbit Chem Pharmaceuticals Private Limited, Gifs Plus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Prashant Bishnoi was appointed as Director on 28 Aug 2020. Ram Swaroop Bishnoi was appointed as Director on 28 Aug 2020.
Yes, NBM Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-22-0035087).
The registered office of NBM Pharmaceuticals is at N 1643 Pn 38 Virender Nagar, Jodhpur, Rajasthan, India – 342007.
NBM Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.